NCT05211401View on ClinicalTrials.gov

Rituximab in Patients With ST-elevation Myocardial Infarction

PHASE2RecruitingINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

April 30, 2027

Conditions
ST Elevated Myocardial Infarction
Interventions
DRUG

Active arm 1000 mg

Active arm 1000 mg: 1 bag containing 1000 mg of rituximab\* in 500 ml of NaCl 0.9% \* Mabthera® and all registered biosimilars are likely to be used in this trial

DRUG

Placebo arm

Placebo arm: 1 bag of 500 ml of NaCl 0.9%

Trial Locations (1)

75018

RECRUITING

Cardiology department, Hôpital Bichat, AP-HP, Paris

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER